# BioPharmSignal vs MarketBeat FDA Calendar: Which Biotech News Tool Is Better? Canonical URL: https://biopharmsignal.com/compare/biopharmsignal-vs-marketbeat-fda-calendar Competitor category: General investor FDA calendar Last updated: 2026-07-19 Compare BioPharmSignal and MarketBeat FDA Calendar for PDUFA date tracking, biotech catalyst monitoring, stock news, company pages, and alerts. ## Quick Verdict - BioPharmSignal is better when FDA dates need to sit beside biotech news, company pages, sector context, and alerts. - MarketBeat FDA Calendar may fit users who want a general investor-facing FDA calendar. - BioPharmSignal is more specialized for biotech monitoring rather than broad market browsing. ## Choose BioPharmSignal If - Users who track FDA milestones and company news together. - Biotech-focused readers who want ticker-level context. - People who want alerts tied to the companies and keywords they follow. ## Choose MarketBeat FDA Calendar If - General investors who already use MarketBeat. - Users who want a simple public FDA calendar reference. - People who do not need biotech-specific news and alert workflows. ## Feature Comparison ### FDA calendar - BioPharmSignal: Includes a PDUFA Calendar for upcoming FDA decision milestones, with company context one click away. - MarketBeat FDA Calendar: Provides a general investor-facing FDA calendar. ### Biotech specialization - BioPharmSignal: Built specifically around biotech and pharma news, catalysts, tickers, company pages, sector pages, and PDUFA monitoring. - MarketBeat FDA Calendar: Part of a broader stock-market information product. ### Live news - BioPharmSignal: LiveFeed is part of the core product. - MarketBeat FDA Calendar: News exists in a broader stock-market context. ### Alerts - BioPharmSignal: Supports ticker and keyword alert workflows with browser push and webhook delivery for teams that need fast updates. - MarketBeat FDA Calendar: Alert workflow depends on the broader MarketBeat product. ### Company context - BioPharmSignal: Connects news to company profiles, stock data, recent headlines, sector tags, and related company discovery. - MarketBeat FDA Calendar: Company context is broader market context, not only biotech catalyst context. ### Pricing and total cost - BioPharmSignal: Lightweight pricing with a $0 Free plan, Pro at $9.9/month or $95/year, and Ultra at $29/month or $287/year. - MarketBeat FDA Calendar: MarketBeat publicly lists a free tier plus All Access at $29/month or $249/year. ## Pricing And Total Cost BioPharmSignal has a $0 Free plan, Pro at $9.9/month or $95/year, and Ultra at $29/month or $287/year. MarketBeat FDA Calendar: MarketBeat publicly lists a free tier plus All Access at $29/month or $249/year. The fair pricing comparison is not only subscription price. It is the total cost of getting timely biotech headlines, ticker context, PDUFA visibility, watch rules, and alert delivery in one place. ## Analysis ### A biotech-first FDA calendar MarketBeat FDA Calendar can be useful as a public reference. BioPharmSignal is designed around the biotech workflow around that date: what company is involved, what recent news changed, which ticker should be watched, and whether the event belongs in an alert workflow. ### Why the surrounding workflow matters A PDUFA date is rarely useful in isolation. Users often need the latest company update, source link, related news, and a way to follow the ticker. BioPharmSignal places those steps closer together. ### When MarketBeat may be enough For general investors who occasionally check FDA dates, MarketBeat may be enough. For users who follow biotech catalysts daily, BioPharmSignal is more focused. ## FAQ ### Is BioPharmSignal only an FDA calendar? No. It includes a PDUFA Calendar, but also LiveFeed, company pages, sector pages, stock data, and alerts. ### Which is better for biotech-specific monitoring? BioPharmSignal is more specialized for biotech and pharma monitoring. ### Can I use BioPharmSignal to track PDUFA dates? Yes. The PDUFA Calendar is a core product page.